Lymphoma epidemiology in Korea and the real clinical field including the Consortium for Improving Survival of Lymphoma (CISL) trial
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Lymphoma epidemiology in Korea and the real clinical field including the Consortium for Improving Survival of Lymphoma (CISL) trial
Authors
Keywords
Lymphoma, Korea, Epidemiology, Clinical trial
Journal
INTERNATIONAL JOURNAL OF HEMATOLOGY
Volume 107, Issue 4, Pages 395-404
Publisher
Springer Nature
Online
2018-01-22
DOI
10.1007/s12185-018-2403-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nationwide Statistical Analysis of Lymphoid Malignancies in Korea
- (2018) Hyewon Lee et al. Cancer Research and Treatment
- A phase II study of everolimus (RAD001), an mTOR inhibitor plus CHOP for newly diagnosed peripheral T-cell lymphomas
- (2016) S. J. Kim et al. ANNALS OF ONCOLOGY
- The 2016 revision of the World Health Organization classification of lymphoid neoplasms
- (2016) S. H. Swerdlow et al. BLOOD
- Cancer treatment and survivorship statistics, 2016
- (2016) Kimberly D. Miller et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Results of a phase II study of vorinostat in combination with intravenous fludarabine, mitoxantrone, and dexamethasone in patients with relapsed or refractory mantle cell lymphoma: an interim analysis
- (2016) Dong-Yeop Shin et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Subtype-specific incidence rates of lymphoid malignancies in Hong Kong compared to the United States, 2001⿿2010
- (2016) Bryan A. Bassig et al. Cancer Epidemiology
- Clinical Features and Survival of Patients With Follicular Lymphoma in Korea
- (2016) Su-Hee Cho et al. Clinical Lymphoma Myeloma & Leukemia
- A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis
- (2016) Seok Jin Kim et al. LANCET ONCOLOGY
- Extranodal NK/T Cell Lymphoma, Nasal Type (ENKTL-NT): An Update on Epidemiology, Clinical Presentation, and Natural History in North American and European Cases
- (2016) Bradley M. Haverkos et al. Current Hematologic Malignancy Reports
- Salvage chemotherapy of gemcitabine, dexamethasone, and cisplatin (GDP) for patients with relapsed or refractory peripheral T-cell lymphomas: a consortium for improving survival of lymphoma (CISL) trial
- (2015) Byeong-Bae Park et al. ANNALS OF HEMATOLOGY
- Is there role of additional chemotherapy after definitive local treatment for stage I/II marginal zone lymphoma?: Consortium for Improving Survival of Lymphoma (CISL) study
- (2015) Myeong Seok Koh et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- A phase II study of oxaliplatin and prednisone for patients with relapsed or refractory marginal zone lymphoma: Consortium for Improving Survival of Lymphoma trial
- (2015) Sung Yong Oh et al. LEUKEMIA & LYMPHOMA
- Concurrent chemoradiotherapy followed by l-asparaginase-containing chemotherapy, VIDL, for localized nasal extranodal NK/T cell lymphoma: CISL08-01 phase II study
- (2014) Seok Jin Kim et al. ANNALS OF HEMATOLOGY
- Weekly rituximab consolidation following four cycles of R-CHOP induction chemotherapy in very elderly patients with diffuse large B-cell lymphoma: Consortium for improving survival of lymphoma study (CISL)
- (2014) Sung-Hoon Jung et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Clinical outcome and prognosis of patients with primary sinonasal tract diffuse large B-cell lymphoma treated with rituximab-cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy: a study by the Consortium for Improving Survival of Lymphoma
- (2014) Gyeong-Won Lee et al. LEUKEMIA & LYMPHOMA
- Treatment Outcomes of Rituximab Plus Hyper-CVAD in Korean Patients with Sporadic Burkitt or Burkitt-like Lymphoma: Results of a Multicenter Analysis
- (2014) Junshik Hong et al. Cancer Research and Treatment
- High-Dose Etoposide Plus Granulocyte Colony-Stimulating Factor as an Effective Chemomobilization Regimen for Autologous Stem Cell Transplantation in Patients with Non-Hodgkin Lymphoma Previously Treated with CHOP-based Chemotherapy: A Study from the Consortium for Improving Survival of Lymphoma
- (2013) Shin Young Hyun et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Differences in incidence and trends of haematological malignancies in Japan and the United States
- (2013) Dai Chihara et al. BRITISH JOURNAL OF HAEMATOLOGY
- Repeated radioimmunotherapy with 131I-rituximab for patients with low-grade and aggressive relapsed or refractory B cell non-Hodgkin lymphoma
- (2013) Hye Jin Kang et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Clinical significance of cytogenetic aberrations in bone marrow of patients with diffuse large B-cell lymphoma: prognostic significance and relevance to histologic involvement
- (2013) Seon Kim et al. Journal of Hematology & Oncology
- Extranodal natural killer/T-cell lymphoma from skin or soft tissue: suggestion of treatment from multinational retrospective analysis
- (2012) H. K. Ahn et al. ANNALS OF ONCOLOGY
- SMILE for natural killer/T-cell lymphoma: analysis of safety and efficacy from the Asia Lymphoma Study Group
- (2012) Y.-L. Kwong et al. BLOOD
- Bortezomib in combination with CHOP as first-line treatment for patients with stage III/IV peripheral T-cell lymphomas: A multicentre, single-arm, phase 2 trial
- (2012) Seok Jin Kim et al. EUROPEAN JOURNAL OF CANCER
- Waldeyer’s ring marginal zone B cell lymphoma: are the clinical and prognostic features nodal or extranodal? A study by the Consortium for Improving Survival of Lymphoma (CISL)
- (2012) Sung Yong Oh et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Prognostic factors in primary diffuse large B-cell lymphoma of adrenal gland treated with rituximab-CHOP chemotherapy from the Consortium for Improving Survival of Lymphoma (CISL)
- (2012) Yu Kim et al. Journal of Hematology & Oncology
- Non-bacterial infections in Asian patients treated with alemtuzumab: a retrospective study of the Asian Lymphoma Study Group
- (2012) Seok Jin Kim et al. LEUKEMIA & LYMPHOMA
- Primary Thyroid Marginal Zone B-Cell Lymphoma of the Mucosa-Associated Lymphoid Tissue Type: Clinical Manifestation and Outcome of a Rare Disease – Consortium for Improving Survival of Lymphoma Study
- (2011) Sung Yong Oh et al. ACTA HAEMATOLOGICA
- Clinical features and outcomes of Hodgkin’s lymphoma in Korea: Consortium for Improving Survival of Lymphoma (CISL)
- (2011) Young-Woong Won et al. ANNALS OF HEMATOLOGY
- Phase II trial of rituximab plus CVP combination chemotherapy for advanced stage marginal zone lymphoma as a first-line therapy: Consortium for Improving Survival of Lymphoma (CISL) study
- (2011) Hye Jin Kang et al. ANNALS OF HEMATOLOGY
- Radioimmunotherapy with 131I-rituximab for patients with relapsed/refractory B-cell non-Hodgkin's lymphoma (NHL)
- (2011) Hye J KANG et al. Asia-Pacific Journal of Clinical Oncology
- The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications
- (2011) E. Campo et al. BLOOD
- Survival of European patients diagnosed with lymphoid neoplasms in 2000-2002: results of the HAEMACARE project
- (2011) R. Marcos-Gragera et al. HAEMATOLOGICA
- Matched-pair analysis comparing the outcomes of primary breast and nodal diffuse large B-cell lymphoma in patients treated with rituximab plus chemotherapy
- (2011) Ho-Young Yhim et al. INTERNATIONAL JOURNAL OF CANCER
- Lymphopenia is an important prognostic factor in peripheral T-cell lymphoma (NOS) treated with anthracycline-containing chemotherapy
- (2011) Yu Ri Kim et al. Journal of Hematology & Oncology
- Pilot trial of yttrium-90 ibritumomab tiuxetan consolidation following rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone chemotherapy in patients with limited-stage, bulky diffuse large B-cell lymphoma
- (2011) Deok-Hwan Yang et al. LEUKEMIA & LYMPHOMA
- Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study
- (2010) A. Jaccard et al. BLOOD
- Comparison of treatment strategies for patients with intestinal diffuse large B-cell lymphoma: surgical resection followed by chemotherapy versus chemotherapy alone
- (2010) S. J. Kim et al. BLOOD
- Clinical outcomes and prognostic factors in patients with breast diffuse large B cell lymphoma; Consortium for Improving Survival of Lymphoma (CISL) study
- (2010) Ho-Young Yhim et al. BMC CANCER
- Stage IV marginal zone B-cell lymphoma - prognostic factors and the role of rituximab: Consortium for Improving Survival of Lymphoma (CISL) study
- (2010) Sung Yong Oh et al. CANCER SCIENCE
- Modified Number of Extranodal Involved Sites as a Prognosticator in R-CHOP-Treated Patients with Disseminated Diffuse Large B-Cell Lymphoma
- (2010) Changhoon Yoo et al. KOREAN JOURNAL OF INTERNAL MEDICINE
- Pulmonary marginal zone B-cell lymphoma of MALT type—What is a prognostic factor and which is the optimal treatment, operation, or chemotherapy?: Consortium for Improving Survival of Lymphoma (CISL) Study
- (2009) Sung Yong Oh et al. ANNALS OF HEMATOLOGY
- Alemtuzumab and DHAP (A-DHAP) is effective for relapsed peripheral T-cell lymphoma, unspecified: interim results of a phase II prospective study
- (2009) S. J. Kim et al. ANNALS OF ONCOLOGY
- When do we need central nervous system prophylaxis in patients with extranodal NK/T-cell lymphoma, nasal type?
- (2009) S. J. Kim et al. ANNALS OF ONCOLOGY
- Phase II study of Gemcitabine for treatment of patients with advanced stage marginal zone B-cell lymphoma: Consortium for Improving Survival of Lymphoma (CISL) trial
- (2009) Sung Yong Oh et al. INVESTIGATIONAL NEW DRUGS
- Salvage therapy with gemcitabine, ifosfamide, dexamethasone, and oxaliplatin (GIDOX) for B-cell non-Hodgkin’s lymphoma: a consortium for improving survival of lymphoma (CISL) trial
- (2009) Byeong-Bae Park et al. INVESTIGATIONAL NEW DRUGS
- Phase II Trial of Concurrent Radiation and Weekly Cisplatin Followed by VIPD Chemotherapy in Newly Diagnosed, Stage IE to IIE, Nasal, Extranodal NK/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma Study
- (2009) Seok Jin Kim et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I study of proteasome inhibitor bortezomib plus CHOP in patients with advanced, aggressive T-cell or NK/T-cell lymphoma
- (2008) J. Lee et al. ANNALS OF ONCOLOGY
- A multicenter phase II trial of etoposide, methylprednisolone, high-dose cytarabine, and oxaliplatin for patients with primary refractory/relapsed aggressive non-Hodgkin’s lymphoma
- (2008) Sun Jin Sym et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Nasal NK/T-cell lymphoma: epidemiology and pathogenesis
- (2008) Katsuyuki Aozasa et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now